TCT 2017: Dr. C. Michael Gibson talks with Dr. Stephen Ellis about ABSORB III

3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease